Whole foods: Wherever possible, try to eat food that is as close to its natural form as possible
For example, in the SELECT trial (17,600 patients with cardiovascular disease and obesity but without T2D), weekly subcutaneous Semaglutide (2.4 mg) reduced the risk of major adverse cardiovascular events (MACE heart attack, stroke, or cardiovascular death) by 20% compared to placebo (HR 0.80
This product is not intended to replace a varied and balanced nutrition
Learn how KLOW Peptide Blend combines GHK-Cu, BPC-157, TB-500, and KPV to support healing from multiple angles
What constitutes unresponsive: Clinically, per manufacture, a patient should not be considered as unresponsive to therapy until less than 5% weight loss over the course of 3 months of Semaglutide at 2.4 mg=100 units/wk has been established
Our Glutathione products are 100% original with no side effects